retatrutide ly3437943 glp-1 gip glucagon receptor agonist 𧬠R3TA is a next-generation peptide being studied for its unique triple- approach to metabolic health. Unlike traditional therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, LY3437943, a novel triple GIP,
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
02033-5/asset/e4c9417f-3cd1-4983-b1a9-6c6b1c8112ee/main.assets/gr2_lrg.jpg)




























